Screener
Bio-Rad Laboratories BIO Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| LIABILITIES AND STOCKHOLDERS’ EQUITY | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Total current liabilities | 917.0 | 517.0 |
| Long-term debt, net of current maturities | 802.9 | 1,201.7 |
| Deferred income taxes | 881.8 | 1,059.4 |
| Operating lease liabilities | 138.6 | 145.7 |
| Other long-term liabilities | 198.4 | 199.1 |
| Total liabilities | 2,938.7 | 3,122.9 |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 7,500,000 shares authorized; issued and outstanding - none | — | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's operating lease liabilities?
- Bio-Rad Laboratories (BIO) reported operating lease liabilities of $138.6M in Q1 2026.
- How has Bio-Rad Laboratories's operating lease liabilities changed year-over-year?
- Bio-Rad Laboratories's operating lease liabilities increased by 9.7% year-over-year, from $126.3M to $138.6M.
- What is the long-term trend for Bio-Rad Laboratories's operating lease liabilities?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's operating lease liabilities has grown at a -3.6% compound annual growth rate (CAGR), from $175.13M to $145.7M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Bio-Rad Laboratories's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude